Department of Biochemistry and Molecular Genetics Seminar with Tullia Bruno, PhD
Thursday, January 29, 2026
Speaker: Tullia Bruno
Assistant Professor of Immunology
University of Pittsburgh School of Medicine
UPMC Hillman Cancer Center
Member, Tumor Microenvironment Center
Member, Cancer Immunology and Immunotherapy Program
Scientific Director, Cytometry Facility (CF), UPMC Hillman
Topic: Harnessing B Cells Inside and Outside of Tertiary Lymphoid Structures for Improved Anti-Tumor Immunity
Time: Noon – 1 p.m.
Location: Molecular Biology Research Building
Herman Auditorium
900 S. Ashland Avenue, Chicago, IL 60607
University of Illinois at Chicago, College of Medicine
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
More About the Speaker: Bruno obtained her PhD in Immunology from Johns Hopkins in 2010 and completed her postdoctoral fellowship at the University of Colorado in 2015, both with a focus on tumor immunology. While her PhD training focused on inhibitory receptors on intertumoral T cells, she became interested in the role of B cells and tertiary lymphoid structures (TLS) in the tumor microenvironment (TME) during her postdoctoral fellowship and has built her independent research program around understanding intertumoral B cell and TLS function in multiple human cancers and physiologically relevant murine models. Because her research lab has an overt focus on studying immunity within cancer patients, her research is highly translational with the potential for future clinical trials targeting B cells and TLS. Finally, given her cutting-edge work on analyzing TLS with multispectral imaging and spatial transcriptomics, she is becoming an emerging leader for spatial biology techniques. She is actively involved in the UPMC Hillman community and is an advocate for women in science, as is evidenced by her previous role as chair of the UPMC Hillman Women's Initiatives Taskforce and her contributions to the Society of Immunotherapy's Women in Immunotherapy group.